Isolation of Viable Adipocytes and Stromal Vascular Fraction from Human Visceral Adipose Tissue Suitable for RNA Analysis and Macrophage Phenotyping
October 27th, 2020
This protocol provides an efficient collagenase digestion method for isolation of viable adipocytes and stromal vascular fraction-SVF cells from human visceral fat in a single process, including methodology to obtain high-quality RNA from adipocytes and phenotypification of SVF-macrophages through staining of multiple membrane-bound markers for analysis by flow cytometry.
Overview
This protocol allows for the efficient isolation of viable adipocytes and stromal vascular fraction (SVF) cells from human visceral fat using collagenase digestion. It also includes methods for obtaining high-quality RNA from adipocytes and identifying SVF macrophages through flow cytometry.
Key Study Components
Area of Science
- Cell Biology
- Adipose Tissue Research
- Flow Cytometry
Background
- Adipocytes play a crucial role in metabolic processes.
- SVF cells are important for understanding the immune response in adipose tissue.
- Collagenase digestion is a common method for isolating these cells.
- High-quality RNA is essential for gene expression studies.
Purpose of Study
- To provide a reliable method for isolating viable adipocytes and SVF cells.
- To enable the analysis of RNA from adipocytes.
- To facilitate the identification of macrophages in the SVF.
Methods Used
- Enzymatic digestion with collagenase.
- Isolation of adipocytes and SVF cells from human visceral fat.
- RNA extraction from mature adipocytes.
- Flow cytometry for phenotyping SVF macrophages.
Main Results
- High yields of total RNA suitable for expression analysis.
- Successful identification of macrophages using flow cytometry.
- Guidelines for troubleshooting the isolation process.
- Efficient single-process methodology for cell isolation.
Conclusions
- The protocol provides a streamlined approach for studying adipose tissue.
- It enhances the understanding of adipocyte and macrophage biology.
- The method is applicable for various research needs in metabolic studies.
Frequently Asked Questions
Executive Industry Relevance
This protocol enables biopharma researchers to isolate viable adipocytes and stromal vascular fraction (SVF) cells from human visceral adipose tissue in a single workflow, supporting mechanistic de-risking of adipose tissue targets. By providing high-integrity RNA from adipocytes and enabling macrophage phenotyping via flow cytometry, it facilitates target validation and phenotypic screening in metabolic disease research. The method enhances predictive confidence in early discovery by allowing parallel analysis of lipid-storing and immune cell populations within the same tissue sample.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of adipocyte-SVF crosstalk to clarify pathophysiological mechanisms in metabolic disease.
- Operational Value: Provides a standardized process for isolating two functionally distinct cell populations from a single tissue biopsy.
Screening & Assay Development
- Scientific Value: Generates purified SVF suspensions suitable for flow cytometry-based screening of macrophage phenotypes.
- Operational Value: Delivers adipocyte RNA with high integrity and yield, enabling reliable gene expression assays including miRNA profiling.
Translational & Preclinical Research
- Scientific Value: Supports disease-relevant analysis of human visceral adipose tissue, improving translational biomarker alignment.
- Operational Value: Allows isolation of defined macrophage subsets (pro- and anti-inflammatory) for mechanistic de-risking in preclinical models.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation through lead identification, providing molecular and cellular readouts that inform early decision-making in metabolic disease programs.
- Discovery Biology: Supports hypothesis testing by enabling parallel analysis of adipocyte gene expression and SVF immune cell composition.
- Screening: Delivers standardized SVF cell preparations for consistent flow cytometry-based immunophenotyping assays.
- Analytics: Provides quantitative RNA yield and integrity metrics, including miRNA concentration, for downstream expression analysis.
- Translational Research: Uses human visceral adipose tissue to enhance disease relevance and support continuity from discovery to preclinical validation.
- Enterprise Reuse: Establishes a reusable isolation workflow applicable across multiple metabolic disease targets and screening campaigns.
Operational & Enterprise Impact
- Scientific Value: Increases target validation confidence by enabling mechanistic de-risking through dual-cell-type analysis from the same sample.
- Operational Value: Improves reproducibility and standardization of adipose tissue processing across laboratories and teams.
- Strategic Value: Reduces biological attrition by providing early functional readouts on adipocyte and macrophage phenotypes.
- Portfolio Impact: Informs risk-adjusted prioritization of targets based on adipocyte-SVF interaction data.
Implementation Considerations
- Requires expertise in enzymatic tissue dissociation and density-based cell separation.
- Dependent on access to centrifuges, flow cytometers, and RNA integrity analyzers.
- Necessitates standardized reagent preparation and digestion timing for consistent SVF and adipocyte yields.
- Requires adaptation of antibody panels for macrophage subset identification across different donor tissues.
- Limited by tissue availability and viability constraints in human biopsy samples.
Biopharma FAQs
Chapters in this video
0:00
Introduction
0:46
Visceral Adipose Tissue Collection and Enzymatic Digestion
2:10
RNA Extraction from Mature Adipocytes and microRNA Quantification Assay
3:16
Characterization of Macrophage Subsets from Stromal Vascular Fraction
4:42
Results: Identification of Macrophages from Visceral Adipose Tissue
6:02
Conclusion
